{"transactions":[{"id":992581,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":72822,"kind":"person","name":"Banks Jerel A.","position":1,"cik":"0001808930","reported_name":"Banks Jerel A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Options (right to buy)","published_at":"2025-11-20T22:36:30.000Z","date":"2025-11-18","kind":"grant","planned":false,"acquired":true,"shares":450000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options will vest in 16 substantially equal quarterly installments commencing on March 31, 2026."}],"balance_after":450000,"derivative":{"exercise_price":13.53,"expiration_date":"2035-11-18","underlying":"Common Stock","underlying_shares":450000},"source":{"system":"sec-edgar","filing":"0001012975-25-000812","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808898/000101297525000812/form4.xml","form_type":"4"}},{"id":1335784,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":72822,"kind":"person","name":"Banks Jerel A.","position":1,"cik":"0001808930","reported_name":"Banks Jerel A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Options (right to buy)","published_at":"2024-12-11T22:19:13.000Z","date":"2024-12-09","kind":"grant","planned":false,"acquired":true,"shares":2310000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options will vest in 16 substantially equal quarterly installments commencing on March 31, 2025."}],"balance_after":2310000,"derivative":{"exercise_price":12.18,"expiration_date":"2034-12-09","underlying":"Common Stock","underlying_shares":2310000},"source":{"system":"sec-edgar","filing":"0001062993-24-020464","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808898/000106299324020464/form4.xml","form_type":"4"}},{"id":1586937,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":72822,"kind":"person","name":"Banks Jerel A.","position":1,"cik":"0001808930","reported_name":"Banks Jerel A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Options (right to buy)","published_at":"2024-03-08T21:13:15.000Z","date":"2024-03-06","kind":"grant","planned":false,"acquired":true,"shares":466554,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options will vest in three substantially equal installments on March 6, 2025, March 6, 2026, and March 6, 2027."}],"balance_after":466554,"derivative":{"exercise_price":5.21,"expiration_date":"2034-03-06","underlying":"Common Stock","underlying_shares":466554},"source":{"system":"sec-edgar","filing":"0001062993-24-005970","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808898/000106299324005970/form4.xml","form_type":"4"}},{"id":1854533,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":72822,"kind":"person","name":"Banks Jerel A.","position":1,"cik":"0001808930","reported_name":"Banks Jerel A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Options (right to buy)","published_at":"2023-06-15T20:11:50.000Z","date":"2023-06-13","kind":"grant","planned":false,"acquired":true,"shares":356900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options will vest in three substantially equal installments on June 13, 2024, June 13, 2025, and June 13, 2026."}],"balance_after":356900,"derivative":{"exercise_price":0.23,"expiration_date":"2033-06-13","underlying":"Common Stock","underlying_shares":356900},"source":{"system":"sec-edgar","filing":"0001062993-23-013634","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808898/000106299323013634/form4.xml","form_type":"4"}},{"id":2948835,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":72822,"kind":"person","name":"Banks Jerel A.","position":1,"cik":"0001808930","reported_name":"Banks Jerel A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Options (right to buy)","published_at":"2020-12-11T21:51:00.000Z","date":"2020-12-09","kind":"grant","acquired":true,"shares":284345,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options will vest in three substantially equal installments on December 9, 2021, December 9, 2022, and December 9, 2023."}],"balance_after":284345,"derivative":{"exercise_price":2.98,"expiration_date":"2030-12-09","underlying":"Common Stock","underlying_shares":284345},"source":{"system":"sec-edgar","filing":"0001062993-20-006253","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808898/000106299320006253/form4.xml","form_type":"4"}}]}